RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 75mg film coated tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

risedronate sodium hemipentahydrate, Quantity: 86.7 mg

Disponible desde:

GM Pharma International Pty Ltd

Designación común internacional (DCI):

Risedronate sodium hemipentahydrate

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: crospovidone; colloidal anhydrous silica; titanium dioxide; iron oxide red; magnesium stearate; hyprolose; macrogol 8000; hypromellose; lactose

Vía de administración:

Oral

Unidades en paquete:

4, 8, 2, 6

clase:

Medicine Registered

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

The treatment of osteoporosis,The treatment of glucocorticoid-induced osteoporosis,The preservation of bone-mineral density in patients on long term corticosteroid therapy

Resumen del producto:

Visual Identification: Dark pink, round, biconvex coated tablet. Engraved "APO" on one side, "RIS" over "75" on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-03-08